MXC Capital Limited Sells Castleton Shares for £5.5 million.

MXC Capital Limited ORD NPV
[shareaholic app="share_buttons" id_name="post_below_content"]

MXC Capital Limited (LON:MXCP), the technology focused adviser and investor, announced today that on 29 August 2018 it sold 5,685,423 ordinary shares of 2 pence each in the capital of Castleton Technology plc at a price of 97 pence per Castleton Share, resulting in gross proceeds of £5.5 million.

Following the Sale, MXC no longer holds any Castleton Shares. The proceeds of the Sale will be used in line with MXC’s stated strategy of investing in technology companies.

Castleton is a leading supplier of complementary software and managed services to the public and not-for-profit sectors listed on the AIM market of the London Stock Exchange. Further details about Castleton (including latest financial reports) are available at www.castletonplc.com.

MXC Capital Limited is a specialist technology adviser and investor with a track record of investing in and advising companies in the TMT sector. MXC brings together a deep knowledge of technology, first-hand experience of managing companies in the sector, an ability to make meaningful investments and a highly experienced corporate advisory team in support, all of which combine to grow shareholder value.

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:
    Argent BioPharma Ltd, formerly MGC Pharmaceuticals Limited, is a pioneering drug discovery company in the biopharmaceutical sector. Learn about their recent name change and impactful advancements in drug development.

      Search

      Search